Gynecologic oncology
Audio Summaries

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study

Aug 8, 2026

The study aimed to determine health-related utility scores (HRUS) for premenopausal women undergoing risk-reducing hysterectomy (RRH), with and without bilateral salpingo-oophorectomy (BSO), at one and twelve months post-operation. By utilizing a randomized vignette approach with 1001 participants, the authors found significant differences in HRUS across different postoperative scenarios, which are crucial for counseling women at increased risk of endometrial cancer and for health-economic evaluations. The results highlight the importance of understanding quality of life outcomes associated with these surgical interventions.

Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment

Aug 7, 2026

The authors aimed to evaluate the feasibility, adherence, and participant experiences of a home-based cognitive training intervention for gynecologic cancer survivors experiencing cancer-related cognitive impairment (CRCI). The pilot trial demonstrated high feasibility with 98% of participants completing assessments, though adherence to the cognitive training was variable, with only 55% meeting the prescribed usage. Qualitative feedback indicated motivation for participation and areas for improvement in the intervention design, highlighting the need for further refinement before larger efficacy trials.

Factors associated with non-completion of gynecological cancer clinical trials

Aug 7, 2026

The authors aimed to identify trial-level characteristics associated with the non-completion of gynecologic cancer clinical trials. Their analysis of 1,033 trials revealed that 30.3% did not complete, with factors such as intervention type, year of initiation, and U.S. region significantly influencing non-completion rates. The study highlights the need for improved trial design and feasibility planning to enhance the efficiency of gynecologic oncology research.

Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes

Aug 7, 2026

The authors aimed to investigate the distribution of actionable surface targets TROP2, HER2, and FRα in endometrial carcinoma across various histologic, molecular, and genomic subgroups. Their findings revealed that TROP2 is widely expressed, while HER2 and FRα are predominantly found in high-grade serous tumors, particularly those with p53 abnormalities, suggesting the potential for biomarker-informed antibody-drug conjugate (ADC) therapies. The study highlights the need for targeted treatment strategies based on specific tumor characteristics.

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project

Aug 6, 2026

This study aimed to assess the effectiveness of a quality improvement intervention in reducing venous thromboembolism (VTE) rates among ovarian cancer patients receiving first-line chemotherapy. The implementation of a program that included staff education and integrated anticoagulant prescriptions resulted in a significant decrease in VTE rates from 16.9% to 12.5%, without an increase in bleeding complications. The findings suggest that oral anticoagulants can effectively lower VTE risk in this patient population, highlighting the need for improved risk stratification in future studies.

The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma

Aug 4, 2026

The authors aimed to evaluate the feasibility and efficacy of a medically supervised preoperative weight loss program for women with obesity and atypical hyperplasia or low-grade endometrial carcinoma. The study found that participants experienced significant short-term weight loss, with a mean reduction of 15 kg prior to surgery, suggesting that such interventions may be beneficial for this patient population. However, the authors call for larger comparative studies to further assess the perioperative benefits and oncologic safety of preoperative weight loss.

No time to waste: Evaluation of diagnostic delays in vulvar cancer

Aug 3, 2026

The authors aimed to identify the factors contributing to diagnostic delays in vulvar squamous cell cancer (SCC). Their study found that delays were primarily associated with provider and healthcare system factors, particularly the initial evaluation by non-gynecologic providers, rather than patient or tumor characteristics. They suggest that improving referral practices and education for both patients and providers could enhance timely diagnosis and treatment.

Pregnancies in gynecologic oncologists: An assessment of pregnancy policies and complications within a surgical subspecialty

Jul 28, 2026

The authors aimed to assess the pregnancy-related experiences, complications, and institutional policies regarding workload adjustments for gynecologic oncologists. Their survey of 276 respondents revealed high rates of pregnancy complications, including a 25% preterm delivery rate, and indicated that very few had access to policies for work-hour reductions during pregnancy. The findings underscore the need for improved support and explicit policies to accommodate the unique challenges faced by pregnant gynecologic oncologists.

Phase 1-3 cross-cultural development and pre-testing of the European Organisation of Research and Treatment of Cancer Vulva cancer questionnaire module (EORTC QLQ- VU)

Jul 23, 2026

The authors aimed to develop and pre-test a quality of life measure specifically for vulva cancer patients to complement the existing EORTC QLQ-C30 questionnaire, ensuring its content validity and cross-cultural adaptability. Through a systematic literature review and input from patients and healthcare professionals, they identified key quality of life issues, resulting in a provisional questionnaire (EORTC QLQ-VU) consisting of 36 items, which underwent pre-testing across multiple European centers. The findings indicated high relevance and applicability of the questionnaire, with further psychometric validation planned.

Clitoral reconstructive surgery for patients with vulvar carcinoma

Jul 21, 2026

The authors aim to evaluate the feasibility and outcomes of clitoral reconstructive surgery in patients with vulvar carcinoma, particularly after oncological excision. They describe a surgical technique that preserves neurovascular integrity and restores clitoral anatomy, reporting a high rate of postoperative clitoral sensation and orgasm (88.9%) with a low complication rate (11.1%). The study suggests that clitoral reconstruction can mitigate psychosexual morbidity while maintaining oncological safety, warranting further prospective evaluation.